Autologous NK Cells therapy(The First Affiliated Hospital With Nanjing Medical University)

N/A

Report date: 2025/09/23 20:00:05

Base Information

Drug NameAutologous NK Cells therapy(The First Affiliated Hospital With Nanjing Medical University)
Drug Alias NameKN5001KN-5001
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsUpdating
Therapy Area/IndicationsSolitary Pulmonary NoduleMultiple Pulmonary Nodules
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesThe First Affiliated Hospital With Nanjing Medical University
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital With Nanjing Medical University
Inactive CompaniesN/A
Active IndicationsSolitary Pulmonary NoduleMultiple Pulmonary Nodules
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A